Bregal Milestone Announces Majority Growth Investment in CoreGo, a Leading European Open-Loop Payment and Event Technology Company
29.4.2026 10:00:00 CEST | Business Wire | Press release
Investment follows over 98% annual growth and supports CoreGo’s continued market expansion
Bregal Milestone, a leading European software growth private equity firm, today announced a majority strategic growth investment in CoreGo Oy ("CoreGo" or the "Company"), a leading provider of open-loop payments and integrated technology solutions for festivals, sports events, and venues across Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427991105/en/
Founded in Helsinki in 2015 by Hannu Elomaa and CTO Nikoteemu Väänänen, CoreGo has built one of Europe's most differentiated open-loop payment infrastructure and event technology businesses. Serving approximately 250 customers across the Nordics and DACH region, the Company delivers an integrated showtime-critical suite of solutions through CoreGo Cloud, unifying payments, access, networks, and data into a single real-time operating system.
CoreGo’s in-house private network capability, the only such offering among pure-play event technology providers in Europe, enables reliable, zero-downtime payment and data operations at scale. Marquee deployments include the Adele in Munich concert residency, which drew more than 730,000 fans across 10 shows, Secto Rally Finland, the largest annual event in the Nordics, and the World Ski Championships 2025.
“We built CoreGo from the ground up – bootstrapped and with a clear focus on technology that performs in the most demanding live environments,” said CoreGo’s Founder and CEO, Hannu Elomaa. “Partnering with Bregal Milestone gives us the backing and expertise to take it further – into new markets and the next generation of our platform.”
In FY2025, CoreGo reported over 98% year-on-year profitable revenue growth, underpinned by a strong recurring revenue base and gross margins above 85%. Bregal Milestone’s investment will support the Company’s European expansion as it leverages commercial partnerships with global platforms, advances AI capabilities within its digital solutions, and further expands the product suite into additional modules.
“CoreGo has become the infrastructure of choice for many of Europe’s most demanding live events,” said Cyrus Shey, Co-Founder and Managing Partner at Bregal Milestone. “Its customer retention and ability to operate at scale demonstrate the strength of its offering. With open-loop payments still in the early stages of adoption across European live events, CoreGo is exceptionally well-positioned to lead that shift. We are excited to partner with Hannu and the team in the next phase of growth.”
The investment is made in partnership with founder and CEO Hannu Elomaa and the CoreGo management team.
Carner Corporate Finance Oy acted as the exclusive financial advisor to the owners of CoreGo. Alvarez & Marsal and White & Case acted as financial and legal advisors to Bregal Milestone. Terms of the transaction were not disclosed.
About CoreGo
CoreGo is a European open-loop payment and event technology solutions company providing integrated solutions for festivals, sports events, and venues. Founded in Helsinki in 2015, the company’s platform combines payments, access control, private network infrastructure, and real-time analytics into a unified system designed for high-volume live environments. CoreGo operates across the Nordics and DACH region, serving approximately 250 customers. For more information, visit www.corego.com or follow us on LinkedIn.
About Bregal Milestone
Bregal Milestone is a leading software private equity firm with c. €2 billion of capital raised since inception. The firm provides growth capital and operational support to build market-leading software companies. Bregal Milestone is part of Bregal Investments, a leading global investment platform with assets under management of over €19 billion. Bregal Milestone was recognized by GrowthCap as one of the Top Private Equity Firms of 2025. For more information, visit www.bregalmilestone.com or follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260427991105/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 12:00:00 CEST | Press release
TEVIMBRA plus ZIIHERA and chemotherapy regimen delivered statistically significant median OS of 26.4 months, an unprecedented result in this challenging diseaseResults from the global Phase 3 HERIZON-GEA-01 study demonstrate potential to change clinical practice in advanced HER2+ gastroesophageal adenocarcinoma BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indica
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 11:30:00 CEST | Press release
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt
Andreas Goppelt Appointed Managing Director of OrphaCare29.4.2026 10:27:00 CEST | Press release
OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/ Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart) Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments. In his new role,
The Jury Has Been Announced for the Third Edition of the Reply AI Film Festival, Dedicated to the Best Short Films Generated With Artificial Intelligence29.4.2026 10:00:00 CEST | Press release
Gabriele Salvatores, together with Rob Minkoff, Catherine Hardwicke, Jed Weintrob, Christina Lee Storm, Nils Hartmann, Guillem Martinez Roura, Filippo Rizzante, Giacomo Mineo, Brian Welk and Denise Negri, will judge the short films in competition based on creativity, production quality and the use of Artificial Intelligence. Reply [EXM, STAR: REY], an international group specialized in creating new business models enabled by AI and long committed to guiding younger generations in exploring emerging technologies, presents the jury of the third edition of the Reply AI Film Festival, the international competition aimed at creatives, directors, and filmmakers who want to challenge themselves in producing short films created using Artificial Intelligence tools. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429288361/en/ “Imaginatio Nova” is the theme of the 2026 edition, an invitation to explore a new phase of imagination, wh
Vonage Named a Leader in the 2026 IDC MarketScape for Worldwide Communications Engagement Platforms29.4.2026 09:30:00 CEST | Press release
Vonage, a part of Ericsson (NASDAQ: ERIC), today announced that it has been positioned in the Leaders Category in the 2026 IDC MarketScape for the Worldwide Communications Engagement Platforms (CEP) sector. Vonage believes this recognition reflects Vonage's comprehensive communications platform that enables enterprises to reimagine customer and employee engagement at global scale. The IDC MarketScape: Worldwide Communications Engagement Platforms 2026 Vendor Assessment (Doc #US53542326, April 2026) provides a comprehensive assessment of select communications engagement platform (CEP) vendors, highlighting their strengths, challenges, and strategic direction to guide technology buyers in making informed decisions. Vonage believes its placement in the Leaders Category underscores the breadth and depth of its portfolio, underpinned by advanced AI capabilities. Built with enterprise businesses and developers in mind, Vonage provides the tools and flexibility to quickly build and customize
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom